KRAS and colorectal carcinoma: We observed high levels of peroxisomal lipid ROS and dysregulation of peroxisomal function in KrasG12D CRC cells compared with KrasWT CRC cells, suggesting that revealing and targeting the underlying mechanisms of peroxisomes in KrasG12D CRC could provide a possible strategy to develop effective therapeutic intervention against Kras-dependent malignancies.